Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Xenova, QSV Biologics Ltd. deal

XEN sold its Canadian manufacturing facilities to QSV Biologics for £2.9

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE